Article Text

Download PDFPDF

Original research
Budget impact analysis of PCSK9 inhibitors costs from a community payers’ perspective in Apulia, Italy
  1. Natale Daniele Brunetti1,
  2. Luisa De Gennaro2,
  3. Lucia Tricarico1 and
  4. Pasquale Caldarola2
  1. 1Università degli Studi di Foggia, Foggia, Italy
  2. 2Presidio Ospedaliero San Paolo, Bari, Italy
  1. Correspondence to Dr Natale Daniele Brunetti; nd.brunetti{at}unifg.it

Footnotes

  • Contributors PC conducted the study, LT gathered data, NDB analysed data, LDG and NDB wrote the paper, and PC and NDB supervised the study.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests NDB received honoraria from Sanofi as consultant.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement There are no additional data available in this work.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors PC conducted the study, LT gathered data, NDB analysed data, LDG and NDB wrote the paper, and PC and NDB supervised the study.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests NDB received honoraria from Sanofi as consultant.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement There are no additional data available in this work.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.